非悪性血液疾患におけるコロナブースターワクチン接種後のSARS-CoV-2 IgG抗体価の解析

DOI Web Site

書誌事項

タイトル別名
  • Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders
  • ヒアクセイ ケツエキ シッカン ニ オケル コロナブースターワクチン セッシュ ゴ ノ SARS-CoV-2 IgG コウタイカ ノ カイセキ

この論文をさがす

抄録

<p>In our facility, anti-SARS-CoV-2 mRNA vaccines were given to 21 patients, including 8 with aplastic anemia (AA), 3 with pure red cell aplasia (PRCA), and 10 with immune thrombocytopenic purpura (ITP), and IgG antibody titers were assessed one month after vaccinations. After receiving both a second vaccine and a booster shot, all patients with AA/PRCA treated with cyclosporine A aside from one, had IgG titers that were lower than the median levels of healthy controls. Even if prednisolone (PSL) doses did not go over 10 mg/day, ITP patients receiving PSL therapy were unable to achieve adequate levels of IgG after booster immunizations.</p>

収録刊行物

  • 臨床血液

    臨床血液 64 (2), 133-136, 2023

    一般社団法人 日本血液学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ